Because differences in EP parameters may be explained by age (73/19 years in cardiac amyloidosis versus 31/31 years in controls, P<0.005), a secondary analysis was performed by comparing 10 cardiac amyloidosis patients (5 ATTR+5 AL) with 10 age‐matched controls. Here, TTR is linked to cardiac amyloidosis.